.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050751

« Back to Dashboard
NDA 050751 describes ATRIDOX, which is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. Additional details are available on the ATRIDOX profile page.

The generic ingredient in ATRIDOX is doxycycline hyclate. There are twenty-seven drug master file entries for this compound. Ninety suppliers are listed for this compound. Additional details are available on the doxycycline hyclate profile page.

Summary for NDA: 050751

Tradename:
ATRIDOX
Applicant:
Tolmar
Ingredient:
doxycycline hyclate
Patents:0
Therapeutic Class:Antibacterials
Dental and Oral Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 050751

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATRIDOX
doxycycline hyclate
SYSTEM, EXTENDED RELEASE;PERIODONTAL 050751 NDA TOLMAR Inc. 63646-191 63646-191-03 2 TRAY in 1 CARTON (63646-191-03) > 1 KIT in 1 TRAY (63646-191-06) * 500 mg in 1 SYRINGE (63646-193-08) * 450 mg in 1 SYRINGE (63646-192-07)
ATRIDOX
doxycycline hyclate
SYSTEM, EXTENDED RELEASE;PERIODONTAL 050751 NDA TOLMAR Inc. 63646-191 63646-191-05 6 TRAY in 1 CARTON (63646-191-05) > 1 KIT in 1 TRAY (63646-191-06) * 500 mg in 1 SYRINGE (63646-193-08) * 450 mg in 1 SYRINGE (63646-192-07)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SYSTEM, EXTENDED RELEASE;PERIODONTALStrength50MG
Approval Date:Sep 3, 1998TE:RLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc